Company Research Report: Andromeda Surgical, Inc.

Company Overview

• Name: Andromeda Surgical, Inc.

• Mission: Empowering surgeons with autonomous precision by building autonomous robots for safer, better, more efficient surgeries, beginning with endourology.

• Founded: 2023

• Founders:

• Nick Damiano, Co-founder & CEO

• Kartik Tiwari, Co-founder & CTO

• Key People:

• Nick Damiano is experienced in founding medtech companies, whose products have been implemented in over 1,000 hospitals globally. He was involved with Zenflow and Nurep (now Avail MedSystems).

• Kartik Tiwari has a background in autonomous vehicles and was pivotal in launching the first driverless truck on US highways with Starsky Robotics.

• Headquarters: South San Francisco, CA, US

• Number of Employees: 2-10

• Revenue: No information is available

• Known For: Developing autonomous surgical robots that leverage AI to improve surgical outcomes and streamline procedures.

Products

• Products Offered:

• Autonomous surgical robots focused initially on endourology procedures.

• High-Level Description:

• The robots utilize AI to aid surgeons in achieving higher accuracy, while reducing operating room times and minimizing complications.

• Key Features:

• Supercharged Abilities: AI guidance enhances precision, optimizing patient outcomes.

• Efficiency Boost: Designed to simplify surgery processes and reduce delays.

• User-friendly Interface: Tailored to facilitate surgeons' transition to robotic procedures, inspired by autonomous vehicle technology.

Recent Developments

• Product Launch:

• Andromeda Surgical has launched its product live in the clinic, achieving the world's first robotic-assisted Holmium laser enucleation of the prostate (HoLEP) procedure.

• FDA Safer Technologies Program:

• The company has been accepted into the FDA’s Safer Technologies Program (STeP), recognizing the potential to improve surgical safety.

• Clinical Trials:

• Enrollment has begun for the ASTRA study in Chile and New Zealand, continuing to test and validate the technology.

• New Partnerships and Team Members:

• Michael Nketiah joined as Chief of Regulatory & Quality, bringing extensive experience in regulatory roles across various medtech companies.

• Innovations:

• Developed AI solutions to enhance surgeons’ cognitive capabilities and lower the occurrence of surgical complications.

• Future Plans:

• Expand into other urologic procedures and beyond to include multi-port laparoscopic procedures.

• Continued hiring for roles such as robotics and HRI/industrial design engineers, and partnerships with urologists for data collection.

No information is available for any additional aspects not covered above, such as specific sponsorships or additional revenues.